Bank Of New York Mellon Corp Aclaris Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

  • $538 Trillion
  • Q3 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024
SELL
$0.92 - $1.44 $45,632 - $71,424
-49,600 Reduced 17.57%
232,771 $289 Million
Q4 2023

Jan 29, 2024
BUY
$0.64 - $6.49 $25,344 - $257,010
39,601 Added 16.31%
282,371 $296 Million
Q3 2023

Oct 24, 2023
BUY
$6.56 - $10.95 $2,256 - $3,766
344 Added 0.14%
242,770 $1.66 Billion
Q2 2023

Aug 03, 2023
BUY
$7.89 - $10.64 $95,910 - $129,339
12,156 Added 5.28%
242,426 $2.51 Billion
Q1 2023

May 09, 2023
BUY
$7.07 - $17.95 $1.63 Million - $4.13 Million
230,270 New
230,270 $1.86 Billion
Q4 2022

Feb 14, 2023
BUY
$14.33 - $18.37 $3.32 Million - $4.25 Million
231,613 New
231,613 $3.65 Million
Q3 2022

Nov 14, 2022
BUY
$13.07 - $18.22 $414,096 - $577,264
31,683 Added 15.67%
233,882 $3.68 Million
Q2 2022

Aug 15, 2022
BUY
$10.16 - $17.08 $168,686 - $283,579
16,603 Added 8.95%
202,199 $2.82 Million
Q1 2022

May 11, 2022
SELL
$9.74 - $17.92 $7,071 - $13,009
-726 Reduced 0.39%
185,596 $3.2 Million
Q4 2021

Feb 11, 2022
BUY
$12.27 - $18.49 $50,024 - $75,383
4,077 Added 2.24%
186,322 $2.71 Million
Q3 2021

Nov 12, 2021
BUY
$13.38 - $18.8 $628,900 - $883,656
47,003 Added 34.75%
182,245 $3.28 Million
Q2 2021

Aug 11, 2021
BUY
$17.08 - $29.6 $411,388 - $712,945
24,086 Added 21.67%
135,242 $2.37 Million
Q1 2021

May 13, 2021
BUY
$5.86 - $27.73 $38,306 - $181,271
6,537 Added 6.25%
111,156 $2.8 Million
Q4 2020

Feb 09, 2021
SELL
$2.65 - $7.61 $12,174 - $34,960
-4,594 Reduced 4.21%
104,619 $676,000
Q2 2020

Aug 12, 2020
SELL
$1.04 - $1.73 $112,912 - $187,826
-108,570 Reduced 49.85%
109,213 $176,000
Q1 2020

May 06, 2020
SELL
$0.75 - $2.18 $1,497 - $4,351
-1,996 Reduced 0.91%
217,783 $226,000
Q4 2019

Feb 14, 2020
BUY
$1.02 - $1.97 $97,437 - $188,188
95,527 Added 76.88%
219,779 $415,000
Q3 2019

Nov 07, 2019
SELL
$0.79 - $2.47 $32,356 - $101,163
-40,957 Reduced 24.79%
124,252 $134,000
Q2 2019

Aug 12, 2019
SELL
$2.13 - $7.06 $84,392 - $279,724
-39,621 Reduced 19.34%
165,209 $362,000
Q1 2019

May 14, 2019
BUY
$5.63 - $7.84 $38,250 - $53,264
6,794 Added 3.43%
204,830 $1.23 Million
Q4 2018

Feb 11, 2019
SELL
$6.3 - $15.4 $1.41 Million - $3.44 Million
-223,163 Reduced 52.98%
198,036 $1.46 Million
Q3 2018

Nov 09, 2018
SELL
$14.38 - $20.89 $25,912 - $37,643
-1,802 Reduced 0.43%
421,199 $0
Q2 2018

Aug 06, 2018
BUY
$16.46 - $20.33 $515,839 - $637,121
31,339 Added 8.0%
423,001 $8.45 Million
Q1 2018

May 15, 2018
BUY
$17.08 - $25.64 $2.04 Million - $3.06 Million
119,258 Added 43.78%
391,662 $6.86 Million
Q4 2017

Feb 09, 2018
BUY
$21.47 - $27.8 $5.85 Million - $7.57 Million
272,404
272,404 $6.72 Million

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email